Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
Clinical trial NCT07383818 · RECRUITING
Trial details
- NCT number
- NCT07383818
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.